LUMEN TECHNOLOGIES INC (1CYTH.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1CYTH - US5502411037 - Common Stock
9.137 EUR
-0.55 (-5.64%)
1CYTH gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 33 industry peers in the Diversified Telecommunication Services industry. While 1CYTH seems to be doing ok healthwise, there are quite some concerns on its profitability. 1CYTH is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year 1CYTH has reported negative net income.
1CYTH had a positive operating cash flow in the past year.
1CYTH had negative earnings in 4 of the past 5 years.
1CYTH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -4.82%, 1CYTH is doing worse than 80.65% of the companies in the same industry.
The Return On Invested Capital of 1CYTH (0.42%) is worse than 80.65% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1CYTH is below the industry average of 7.68%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.82% | ||
| ROE | N/A | ||
| ROIC | 0.42% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
1.3 Margins
1CYTH's Operating Margin of 1.34% is on the low side compared to the rest of the industry. 1CYTH is outperformed by 80.65% of its industry peers.
In the last couple of years the Operating Margin of 1CYTH has declined.
With a Gross Margin value of 47.07%, 1CYTH is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
1CYTH's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.34% | ||
| PM (TTM) | N/A | ||
| GM | 47.07% |
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 1CYTH is destroying value.
Compared to 1 year ago, 1CYTH has more shares outstanding
1CYTH has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1CYTH has an improved debt to assets ratio.
2.2 Solvency
1CYTH has an Altman-Z score of -0.07. This is a bad value and indicates that 1CYTH is not financially healthy and even has some risk of bankruptcy.
1CYTH's Altman-Z score of -0.07 is on the low side compared to the rest of the industry. 1CYTH is outperformed by 83.87% of its industry peers.
The Debt to FCF ratio of 1CYTH is 14.41, which is on the high side as it means it would take 1CYTH, 14.41 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 14.41, 1CYTH is not doing good in the industry: 67.74% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 14.41 | ||
| Altman-Z | -0.07 |
ROIC/WACC0.07
WACC6.2%
2.3 Liquidity
A Current Ratio of 2.21 indicates that 1CYTH has no problem at all paying its short term obligations.
The Current ratio of 1CYTH (2.21) is better than 93.55% of its industry peers.
1CYTH has a Quick Ratio of 2.17. This indicates that 1CYTH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.17, 1CYTH belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.21 | ||
| Quick Ratio | 2.17 |
3. Growth
3.1 Past
1CYTH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.73%.
Looking at the last year, 1CYTH shows a decrease in Revenue. The Revenue has decreased by -4.56% in the last year.
Measured over the past years, 1CYTH shows a decrease in Revenue. The Revenue has been decreasing by -9.39% on average per year.
EPS 1Y (TTM)-22.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
Revenue 1Y (TTM)-4.56%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-4.16%
3.2 Future
1CYTH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.04% yearly.
Based on estimates for the next years, 1CYTH will show a decrease in Revenue. The Revenue will decrease by -3.84% on average per year.
EPS Next Y-220.63%
EPS Next 2Y-65.27%
EPS Next 3Y-12.74%
EPS Next 5Y18.04%
Revenue Next Year-4.73%
Revenue Next 2Y-5.64%
Revenue Next 3Y-4.34%
Revenue Next 5Y-3.84%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
1CYTH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year 1CYTH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
64.52% of the companies in the same industry are cheaper than 1CYTH, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, 1CYTH is valued a bit cheaper than 70.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.91 | ||
| EV/EBITDA | 8.72 |
4.3 Compensation for Growth
A cheap valuation may be justified as 1CYTH's earnings are expected to decrease with -12.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-65.27%
EPS Next 3Y-12.74%
5. Dividend
5.1 Amount
No dividends for 1CYTH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1CYTH (11/7/2025, 7:00:00 PM)
9.137
-0.55 (-5.64%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)
Earnings (Next)
Inst Owners71.63%
Inst Owner ChangeN/A
Ins Owners7.81%
Ins Owner ChangeN/A
Market Cap9.38B
Revenue(TTM)12.69B
Net Income(TTM)-1.65B
Analysts69
Price Target4.44 (-51.41%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-68.79%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.52%
Min EPS beat(2)26.21%
Max EPS beat(2)88.84%
EPS beat(4)4
Avg EPS beat(4)109.8%
Min EPS beat(4)26.21%
Max EPS beat(4)272.03%
EPS beat(8)5
Avg EPS beat(8)-32.55%
EPS beat(12)8
Avg EPS beat(12)-15.53%
EPS beat(16)9
Avg EPS beat(16)-15.24%
Revenue beat(2)0
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)-0.42%
Revenue beat(4)1
Avg Revenue beat(4)-0.28%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)1.96%
Revenue beat(8)1
Avg Revenue beat(8)-1.07%
Revenue beat(12)1
Avg Revenue beat(12)-1.22%
Revenue beat(16)1
Avg Revenue beat(16)-1.41%
PT rev (1m)-4.36%
PT rev (3m)3.18%
EPS NQ rev (1m)7%
EPS NQ rev (3m)31.59%
EPS NY rev (1m)0.88%
EPS NY rev (3m)33.59%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)-0.17%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.86 | ||
| P/FCF | 8.91 | ||
| P/OCF | 2.25 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.72 |
EPS(TTM)-0.23
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)1.03
FCFY11.23%
OCF(TTM)4.07
OCFY44.54%
SpS10.62
BVpS-0.98
TBVpS-4.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.82% | ||
| ROE | N/A | ||
| ROCE | 0.56% | ||
| ROIC | 0.42% | ||
| ROICexc | 0.46% | ||
| ROICexgc | 0.54% | ||
| OM | 1.34% | ||
| PM (TTM) | N/A | ||
| GM | 47.07% | ||
| FCFM | 9.66% |
ROA(3y)-11.28%
ROA(5y)-6.48%
ROE(3y)-832.11%
ROE(5y)-498.04%
ROIC(3y)3.43%
ROIC(5y)4.35%
ROICexc(3y)3.6%
ROICexc(5y)4.47%
ROICexgc(3y)6.03%
ROICexgc(5y)8.09%
ROCE(3y)4.57%
ROCE(5y)5.8%
ROICexgc growth 3Y-47.53%
ROICexgc growth 5Y-31.85%
ROICexc growth 3Y-41.43%
ROICexc growth 5Y-24.11%
OM growth 3Y-44.91%
OM growth 5Y-27.05%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.94%
GM growth 5Y-3.18%
F-Score5
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 14.41 | ||
| Debt/EBITDA | 5.85 | ||
| Cap/Depr | 128.42% | ||
| Cap/Sales | 28.67% | ||
| Interest Coverage | 0.13 | ||
| Cash Conversion | 161.97% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.21 | ||
| Quick Ratio | 2.17 | ||
| Altman-Z | -0.07 |
F-Score5
WACC6.2%
ROIC/WACC0.07
Cap/Depr(3y)102.09%
Cap/Depr(5y)91.52%
Cap/Sales(3y)21.07%
Cap/Sales(5y)19.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.85%
EPS Next Y-220.63%
EPS Next 2Y-65.27%
EPS Next 3Y-12.74%
EPS Next 5Y18.04%
Revenue 1Y (TTM)-4.56%
Revenue growth 3Y-12.68%
Revenue growth 5Y-9.39%
Sales Q2Q%-4.16%
Revenue Next Year-4.73%
Revenue Next 2Y-5.64%
Revenue Next 3Y-4.34%
Revenue Next 5Y-3.84%
EBIT growth 1Y-62.72%
EBIT growth 3Y-51.9%
EBIT growth 5Y-33.9%
EBIT Next Year399.42%
EBIT Next 3Y75.15%
EBIT Next 5Y38.48%
FCF growth 1Y236.98%
FCF growth 3Y-32.61%
FCF growth 5Y-18.43%
OCF growth 1Y119.4%
OCF growth 3Y-12.65%
OCF growth 5Y-8.29%
LUMEN TECHNOLOGIES INC / 1CYTH.MI FAQ
What is the ChartMill fundamental rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
ChartMill assigns a fundamental rating of 2 / 10 to 1CYTH.MI.
What is the valuation status of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
ChartMill assigns a valuation rating of 1 / 10 to LUMEN TECHNOLOGIES INC (1CYTH.MI). This can be considered as Overvalued.
What is the profitability of 1CYTH stock?
LUMEN TECHNOLOGIES INC (1CYTH.MI) has a profitability rating of 1 / 10.
What is the financial health of LUMEN TECHNOLOGIES INC (1CYTH.MI) stock?
The financial health rating of LUMEN TECHNOLOGIES INC (1CYTH.MI) is 4 / 10.
Can you provide the expected EPS growth for 1CYTH stock?
The Earnings per Share (EPS) of LUMEN TECHNOLOGIES INC (1CYTH.MI) is expected to decline by -220.63% in the next year.